Skip to main content

Table 4 Acute HT2+ during chemoradiotherapy

From: Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?

Characteristic

HT2+

Leukopenia and/or neutropenia

21(21/24, 87.5 %)

Leukopenia and/or neutropenia + anemia

2 (2/24, 8.3 %)

Leukopenia and/or neutropenia + thrombocytopenia

1(1/24, 4.2 %)

Gender

 

  Male

9(9/61, 14.8 %)

  Female

15(15/32, 46.9 %)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us